{
    "organizations": [],
    "uuid": "deca14e9ffc3110d57562414131c36f372f02846",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ra-pharmaceuticals-initiates-dosin/brief-ra-pharmaceuticals-initiates-dosing-in-phase-1b-pharmacokinetic-study-evaluating-ra101495-sc-in-patients-with-renal-impairment-idUSFWN1P30JT",
    "ord_in_thread": 0,
    "title": "BRIEF-Ra Pharmaceuticals Initiates Dosing In Phase 1B Pharmacokinetic Study Evaluating Ra101495 Sc In Patients With Renal Impairment",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Ra Pharmaceuticals Inc:\n* RA PHARMACEUTICALS INITIATES DOSING IN PHASE 1B PHARMACOKINETIC STUDY EVALUATING RA101495 SC IN PATIENTS WITH RENAL IMPAIRMENT Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-08T20:15:00.000+02:00",
    "crawled": "2018-01-09T17:02:01.018+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "ra",
        "pharmaceutical",
        "inc",
        "ra",
        "pharmaceutical",
        "initiate",
        "dosing",
        "phase",
        "1b",
        "pharmacokinetic",
        "study",
        "evaluating",
        "ra101495",
        "sc",
        "patient",
        "renal",
        "impairment",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}